Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00503776
What this trial is testing

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Who this might be right for
DysphagiaHead and Neck CancerMucositis+1 more
Vanderbilt-Ingram Cancer Center 41
Not applicableUnknownNCT01254591
What this trial is testing

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+2 more
University College London (UCL) Cancer Institute 500
Large-scale testing (Phase 3)Active Not RecruitingNCT05063552
What this trial is testing

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
National Cancer Institute (NCI)
Not applicableUnknownNCT05949749
What this trial is testing

A Retrospective Study Reveals the Relationship Between gp42-IgG Epitopes and EBV-associated NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1,000
Testing effectiveness (Phase 2)Study completedNCT01187238
What this trial is testing

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Chinese Academy of Medical Sciences 84
Not applicableStudy completedNCT02575547
What this trial is testing

Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients

Who this might be right for
Nasopharyngeal CarcinomaMalnutrition
Zhao Chong 186
Testing effectiveness (Phase 2)UnknownNCT00816855
What this trial is testing

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 52
Early research (Phase 1)UnknownNCT04522050
What this trial is testing

Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 65
Large-scale testing (Phase 3)Looking for participantsNCT07328841
What this trial is testing

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen 456
Testing effectiveness (Phase 2)Study completedNCT01087970
What this trial is testing

Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Eli Lilly and Company 69
Testing effectiveness (Phase 2)UnknownNCT04548271
What this trial is testing

Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 25
Not applicableEnded earlyNCT02564887
What this trial is testing

Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy

Who this might be right for
DysphagiaOral Pharyngeal Cancer
Jonas Johnson 26
Not applicableStudy completedNCT03398980
What this trial is testing

Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Yuan-hong Gao 94
Not applicableUnknownNCT05432219
What this trial is testing

A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 20
Not applicableEnded earlyNCT00011492
What this trial is testing

Patient Evaluation for Head and Neck Surgery Branch Studies

Who this might be right for
Head and Neck NeoplasmsPharyngeal CancerOral Cancer+2 more
National Institute on Deafness and Other Communication Disorders (NIDCD) 62
Not applicableUnknownNCT04359199
What this trial is testing

QUantitative Assessment of Swallowing After Radiation (QUASAR)

Who this might be right for
Head and Neck CancerDysphagiaOropharyngeal Dysphagia+2 more
Loren Mell, MD 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06605131
What this trial is testing

GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 72
Not applicableLooking for participantsNCT05337631
What this trial is testing

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

Who this might be right for
HNSCCOral Cavity CancerOropharynx Cancer+2 more
University Hospital Freiburg 1,500
Not applicableUnknownNCT04012502
What this trial is testing

De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations

Who this might be right for
Oropharyngeal CarcinomaDe-escalation
Fudan University 83
Not applicableStudy completedNCT01104714
What this trial is testing

Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers

Who this might be right for
Carcinoma, Squamous CellMouth NeoplasmsOropharyngeal Neoplasms+2 more
Centre Hospitalier Universitaire de Nīmes 90
Next Page
430